Manulife (Manufacturers Life Insurance)
INO icon

Manulife (Manufacturers Life Insurance)’s Inovio Pharmaceuticals INO Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,169
Closed -$82.2K – 3025
2024
Q2 		$82.2K Buy
+10,169
New +$107K ﹤0.01% 2874
2023
Q2 		– Sell
-8,060
Closed -$79.3K – 3013
2023
Q1 		$79.3K Hold
8,060
– – ﹤0.01% 2790
2022
Q4 		$151K Buy
8,060
+684
+9% +$15.5K ﹤0.01% 2677
2022
Q3 		$153K Sell
7,376
-164
-2% -$4.2K ﹤0.01% 2692
2022
Q2 		$157K Buy
7,540
+442
+6% +$12.5K ﹤0.01% 2772
2022
Q1 		$306K Sell
7,098
-1,710
-19% -$77K ﹤0.01% 2501
2021
Q4 		$527 Sell
8,808
-117
-1% -$9.37K ﹤0.01% 2223
2021
Q3 		$767K Sell
8,925
-700
-7% -$70.2K ﹤0.01% 2000
2021
Q2 		$1.07M Buy
9,625
+988
+11% +$94.9K ﹤0.01% 1953
2021
Q1 		$962K Buy
8,637
+723
+9% +$95.1K ﹤0.01% 1912
2020
Q4 		$840K Buy
7,914
+457
+6% +$60.8K ﹤0.01% 1923
2020
Q3 		$1.04M Buy
7,457
+383
+5% +$79.9K ﹤0.01% 1642
2020
Q2 		$2.69M Buy
7,074
+1,903
+37% +$306K ﹤0.01% 1316
2020
Q1 		$462K Buy
5,171
+4
+0.1% +$247 ﹤0.01% 1877
2019
Q4 		$205K Sell
5,167
-46
-0.9% -$1.38K ﹤0.01% 2585
2019
Q3 		$132K Hold
5,213
– – ﹤0.01% 2750
2019
Q2 		$184K Buy
5,213
+179
+4% +$7.11K ﹤0.01% 2691
2019
Q1 		$226K Buy
5,034
+544
+12% +$27.4K ﹤0.01% 2372
2018
Q4 		$216K Sell
4,490
-378
-8% -$23K ﹤0.01% 2271
2018
Q3 		$325K Sell
4,868
-792
-14% -$44.1K ﹤0.01% 2505
2018
Q2 		$267K Buy
5,660
+257
+5% +$14.2K ﹤0.01% 2883
2018
Q1 		$305K Sell
5,403
-44
-0.8% -$2.38K ﹤0.01% 2709
2017
Q4 		$269K Buy
5,447
+132
+2% +$8.18K ﹤0.01% 2792
2017
Q3 		$404K Buy
5,315
+759
+17% +$56.5K ﹤0.01% 2421
2017
Q2 		$428K Buy
4,556
+75
+2% +$6.41K ﹤0.01% 2411
2017
Q1 		$356K Buy
4,481
+591
+15% +$47.1K ﹤0.01% 2421
2016
Q4 		$324K Buy
3,890
+82
+2% +$7.42K ﹤0.01% 2420
2016
Q3 		$426K Sell
3,808
-32
-0.8% -$3.54K ﹤0.01% 2179
2016
Q2 		$426K Sell
3,840
-248
-6% -$30.1K ﹤0.01% 2144
2016
Q1 		$423K Buy
4,088
+17
+0.4% +$1.31K ﹤0.01% 2075
2015
Q4 		$328 Buy
4,071
+91
+2% +$7.25K ﹤0.01% 2310
2015
Q3 		$277 Buy
3,980
+51
+1% +$4.44K ﹤0.01% 2395
2015
Q2 		$385 Buy
3,929
+529
+16% +$56.5K ﹤0.01% 2306
2015
Q1 		$333 Buy
3,400
+135
+4% +$13.1K ﹤0.01% 2362
2014
Q4 		$359 Buy
3,265
+13
+0.4% +$1.59K ﹤0.01% 2200
2014
Q3 		$384 Buy
3,252
+34
+1% +$4.24K ﹤0.01% 2159
2014
Q2 		$417K Buy
3,218
+3,068
+2,045% +$362K ﹤0.01% 2167
2014
Q1 		$24 Hold
150
– – ﹤0.01% 3283
2013
Q4 		$21 Buy
150
+28
+23% +$2.8K ﹤0.01% 3277
2013
Q3 		$12 Buy
+122
New +$10.2K ﹤0.01% 3237

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s INO Position: Q3 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Inovio Pharmaceuticals (INO) in Q3 2024, closing a stake of 10,169 shares — an estimated $82.2K sold.

Manulife (Manufacturers Life Insurance) first reported a position in INO in Q3 2013 and held it in 40 quarters. The position peaked at $2.69M in Q2 2020. 98 funds tracked by Wall St. Rank hold INO as of Q3 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Inovio Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 10,169 Inovio Pharmaceuticals shares in Q3 2024, an estimated $82.2K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Inovio Pharmaceuticals in Q3 2013 and held it in 40 quarters.
  • Manulife (Manufacturers Life Insurance)'s Inovio Pharmaceuticals position peaked at $2.69M in Q2 2020.
  • 98 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2024, filed 13 Nov 2024.